Records containing: Skin Rash
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-01-01Goat Milk-based Infant Formula and the Prevalence of Gastrointestinal Symptoms in Infants: a Real-world-evidence Study from Brazil, Mexico, Russia, and the Netherlands
-
CLINICAL_TRIALS study record update · 2024-08-19Evaluation of a Comprehensive School Health Programme in Zambia: a Cluster-randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2023-05-03National Trends In Ambulatory Care Visits For Otitis Media In Children Under The Age Of Five In The United States
-
CLINICAL_TRIALS study record update · 2023-03-29An Open Label, Single-Dose, Single-Treatment, Single-Period Safety and Bioavailability Study of Fexofenadine Hydrochloride Topical Lotion 1% in Healthy, Adult, Male Human Subjects
-
CLINICAL_TRIALS study record update · 2017-11-13Phase III Randomized Double-Blind Trial of Bepanthen® Cream Versus Cetomacrogol Cream in the Prevention of Papulopustular Eruption in Patients Receiving Epidermal Growth Factor Receptor Inhibitors (EGFRI): BeCet
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-04-12Phase II, Open-label, Single Blind, Randomised Clinical Trial With Tetracycline as a Prophylaxis for Rash and Dermatological Recommendations Versus Dermatological Recommendations in Patients With NSCLC Receiving Treatment With BIBW 2992
-
CLINICAL_TRIALS study record update · 2016-02-23A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in Subjects Receiving Second-line FOLFIRI or Irinotecan Only Chemotherapy Concomitantly With Panitumumab
-
CLINICAL_TRIALS study record update · 2013-01-16Pilot Study of Acitretin for Treatment of Erlotinib-induced Skin Rash
-
CLINICAL_TRIALS study record update · 2010-09-23Histological Characterization and Differentiation of Rash From Other EGFR Inhibitors
-
CLINICAL_TRIALS study record update · 2008-02-08Effect of Palifermin Therapy on Benign and Malignant Skin Tumors in Patients Undergoing High-Dose Chemotherapy With Autologous Stem Cell Transplantation